Berwyn biopharm firm sells 2 million shares in first local life sciences IPO of 2020

The proceeds will be used to advance the development of the company's new drug candidates for Parkinson's and Alzheimer's diseases.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.